Indication
Oligo-recurrence
1 clinical trial
8 products
Clinical trial
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer (VA STARPORT)Status: Recruiting, Estimated PCD: 2025-07-01
Product
GoserelinProduct
ADTProduct
Degarelix & RelugolixProduct
ADT + DocetaxelProduct
ADT + ApalutamideProduct
ADT + Enzalutamide